|
Go To |
Headquarters: Website: http://www.merck.com Merck is the world's top pharmaceutical and research company. Merck discovers, develops, manufactures and markets vaccines and medicines in more than 20 therapeutic categories found in 140 countries. The company's top products include: Zetia, which helps reduce cholesterol; Januvia, which treats Type 2 diabetes; Cozaar, used for treating high blood pressure; Singulair, which treats asthma and allergies; Propecia, which helps treat male hair loss. Merck is known as MSD outside of the U.S. and Canada. The company merged with Schering-Plough in 2009. Merck says it has 10 medicines under development this year. The process of drug discovery and development is long and challenging. It begins by first exploring the roots of a disease or condition. If a compound proves promising, it then continues through years of testing and has to obtain regulatory approval before it reaches the market. A very small fraction of the compounds that commence evaluation will ultimately survive the tough process of research, development and testing to finally become medicines. In 2010, Merck reported revenues of $45.9 billion with net income of $982 million. The company spent $10.9 billion on research and development last year. History Established in 1891 by George Merck, the company started off as a fine chemicals supplier. Merck & Co., Inc began its pharmaceutical research in the early 1930's. The merger with Sharp & Dohme to create Merck Sharp & Dohme (MSD) in 1953 established a solid foundation for a fully integrated, multi-national producer and distributor of pharmaceutical products. Merck & Co., Inc acquired Medco Containment Services, Inc. in 1993, the leading pharmacy benefits management company in the United States. Medco was spun off as an independent company in 2003. The company acquired Schering Plough in Dec. 2009 for $41 billion. Benefits - Competitive Base Salary A Flexible Benefits package including: Updated April 1, 2011 |